1-7 of 7
Kai Rejeski
Close
Sort by
Journal Articles

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Munoz, Razan Mohty, Veit L. Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1857–1868.
https://doi.org/10.1182/bloodadvances.2023011767
Published: 2024
Includes: Supplemental data
Journal Articles

Navigating the prognostic role of transfusions after CAR-T

Mohammad Alhomoud, Kai Rejeski
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1570–1572.
https://doi.org/10.1182/bloodadvances.2024012583
Published: 2024
Journal Articles

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Viktoria Blumenberg, Galina Busch, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Laura Gallur, Josu Iraola-Truchuelo, Eva Hoster, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang G. Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L. Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6844–6849.
https://doi.org/10.1182/bloodadvances.2023010364
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study

Clinical Trials & Observations
Francis Ayuk, Nico Gagelmann, Bastian von Tresckow, Gerald Wulf, Kai Rejeski, Matthias Stelljes, Olaf Penack, Claudia D. Baldus, Nicolaus Kröger, Wolfgang Bethge, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5316–5319.
https://doi.org/10.1182/bloodadvances.2023010336
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4719–4725.
https://doi.org/10.1182/bloodadvances.2022007776
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data
Journal Articles

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment

Clinical Trials & Observations
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3022–3026.
https://doi.org/10.1182/bloodadvances.2021006144
Published: 2022